Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KTcol: Ropivacaine Analgesia for Femoral Neck Fracture
NCT01052974Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Mar 2009
- Primary completion
- May 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in femoral neck fracture, sponsored by Centre Hospitalier Universitaire d'Angers. Started Mar 2009; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
femoral neck fracture
Beyond the preview
Go deeper on NCT01052974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052974.